Home/Cambium Bio/Dr. Peter G. O'Connor

DP

Dr. Peter G. O'Connor

CEO

Therapeutic Areas

Dry Eye Disease Knee Osteoarthritis Wound Healing

Cambium Bio Pipeline

Drug	Indication	Phase
Elate Ocular®	Dry Eye Disease	Phase 3
Progenza	Knee Osteoarthritis	Phase 1/2a
Sygenus	Chronic Wound Healing	Phase 1

Leadership Team at Cambium Bio

Prof. James H. McCarthy

Ms. Sarah L. Mitchell

View full Cambium Bio profile